These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 17763956)
1. CV-11974, angiotensin II type I receptor antagonist, reduces the severity of indomethacin-induced rat enteritis. Okuda T; Yoshida N; Takagi T; Handa O; Kokura S; Ichikawa H; Naito Y; Yoshikawa T Dig Dis Sci; 2008 Mar; 53(3):657-63. PubMed ID: 17763956 [TBL] [Abstract][Full Text] [Related]
2. Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis. Kuroda M; Yoshida N; Ichikawa H; Takagi T; Okuda T; Naito Y; Okanoue T; Yoshikawa T Int J Mol Med; 2006 Jan; 17(1):89-93. PubMed ID: 16328016 [TBL] [Abstract][Full Text] [Related]
3. CV-11974, angiotensin II type I receptor antagonist, protects against ischemia-reperfusion injury of the small intestine in rats. Takagi T; Yoshida N; Isozaki Y; Shimozawa M; Katada K; Manabe H; Hanada O; Kokura S; Ichikawa H; Naito Y; Okanoue T; Yoshikawa T Eur J Pharmacol; 2006 Mar; 535(1-3):283-90. PubMed ID: 16545368 [TBL] [Abstract][Full Text] [Related]
4. Mast cells are involved in the pathogenesis of indomethacin-induced rat enteritis. Okayama T; Yoshida N; Uchiyama K; Takagi T; Ichikawa H; Yoshikawa T J Gastroenterol; 2009; 44 Suppl 19():35-9. PubMed ID: 19148791 [TBL] [Abstract][Full Text] [Related]
5. Significance of chymase-dependent matrix metalloproteinase-9 activation on indomethacin-induced small intestinal damages in rats. Kakimoto K; Takai S; Murano M; Ishida K; Yoda Y; Inoue T; Jin D; Umegaki E; Higuchi K J Pharmacol Exp Ther; 2010 Feb; 332(2):684-9. PubMed ID: 19996300 [TBL] [Abstract][Full Text] [Related]
6. Role of tumor necrosis factor-α in the pathogenesis of indomethacin-induced small intestinal injury in mice. Fukumoto K; Naito Y; Takagi T; Yamada S; Horie R; Inoue K; Harusato A; Hirata I; Omatsu T; Mizushima K; Hirai Y; Yoshida N; Uchiyama K; Ishikawa T; Handa O; Konishi H; Wakabayashi N; Yagi N; Kokura S; Ichikawa H; Kita M; Yoshikawa T Int J Mol Med; 2011 Mar; 27(3):353-9. PubMed ID: 21249312 [TBL] [Abstract][Full Text] [Related]
7. Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin II type 1 receptor. Fukuda K; Hirooka K; Mizote M; Nakamura T; Itano T; Shiraga F Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3629-38. PubMed ID: 20164447 [TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory effect of candesartan on indomethacin-induced gastric ulcer in rats. Kamel R; El Morsy EM; Awad AS Immunopharmacol Immunotoxicol; 2012 Dec; 34(6):956-61. PubMed ID: 22889052 [TBL] [Abstract][Full Text] [Related]
9. Diazoxide attenuates indomethacin-induced small intestinal damage in the rat. Menozzi A; Pozzoli C; Poli E; Passeri B; Gianelli P; Bertini S Eur J Pharmacol; 2011 Jan; 650(1):378-83. PubMed ID: 20950601 [TBL] [Abstract][Full Text] [Related]
10. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies. Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021 [TBL] [Abstract][Full Text] [Related]
11. Proinflammatory role of protease-activated receptor-2 in intestinal ischemia/reperfusion injury in rats. Yoshida N; Takagi T; Isozaki Y; Suzuki T; Ichikawa H; Yoshikawa T Mol Med Rep; 2011; 4(1):81-6. PubMed ID: 21461568 [TBL] [Abstract][Full Text] [Related]
12. Involvement of angiotensin II type 1 receptor on pathological remodeling and dysfunction in obstructed bladder. Aikawa K; Sakai T; Ishibashi K; Shiomi H; Sagawa K; Kumagai S; Kataoka M; Akaihata H; Yamaguchi O Int J Urol; 2012 May; 19(5):457-64. PubMed ID: 22320898 [TBL] [Abstract][Full Text] [Related]
13. Protective effect of roxatidine against indomethacin-induced small intestinal mucosal injury in rats. Umegaki E; Yoda Y; Tokioka S; Murano M; Higuchi K J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S35-40. PubMed ID: 20586863 [TBL] [Abstract][Full Text] [Related]
14. Protective effect of pranlukast, a cysteinyl-leukotriene receptor 1 antagonist, on indomethacin-induced small intestinal damage in rats. Nishio H; Hayashi Y; Terashima S; Takeuchi K Inflammopharmacology; 2007 Dec; 15(6):266-72. PubMed ID: 18236018 [TBL] [Abstract][Full Text] [Related]
15. Site-specific lesion formation, inflammation and inducible nitric oxide synthase expression by indomethacin in the rat intestine. Evans SM; László F; Whittle BJ Eur J Pharmacol; 2000 Feb; 388(3):281-5. PubMed ID: 10675738 [TBL] [Abstract][Full Text] [Related]
16. Indomethacin-induced small intestinal injury is ameliorated by cilostazol, a specific PDE-3 inhibitor. Higashiyama M; Hokari R; Kurihara C; Ueda T; Watanabe C; Tomita K; Komoto S; Okada Y; Kawaguchi A; Nagao S; Miura S Scand J Gastroenterol; 2012 Sep; 47(8-9):993-1002. PubMed ID: 22934593 [TBL] [Abstract][Full Text] [Related]
17. Gastroprotective effects of telmisartan on experimentally-induced gastric ulcers in rats. Morsy M; Ashour O; Amin E; Rofaeil R Pharmazie; 2009 Sep; 64(9):590-4. PubMed ID: 19827301 [TBL] [Abstract][Full Text] [Related]
18. Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension. Yu Y; Fukuda N; Yao EH; Matsumoto T; Kobayashi N; Suzuki R; Tahira Y; Ueno T; Matsumoto K Am J Hypertens; 2008 Jan; 21(1):72-7. PubMed ID: 18091747 [TBL] [Abstract][Full Text] [Related]
19. AT1 receptor blocker candesartan-induced attenuation of brain injury of rats subjected to chronic cerebral hypoperfusion. Ozacmak VH; Sayan H; Cetin A; Akyildiz-Igdem A Neurochem Res; 2007 Aug; 32(8):1314-21. PubMed ID: 17401654 [TBL] [Abstract][Full Text] [Related]
20. Activation of α7 nicotinic acetylcholine receptors ameliorates indomethacin-induced small intestinal ulceration in mice. Kawahara R; Yasuda M; Hashimura H; Amagase K; Kato S; Takeuchi K Eur J Pharmacol; 2011 Jan; 650(1):411-7. PubMed ID: 20969854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]